U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
--------------------------------------------------------------------------------
[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES
EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2002
or
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
For the transition period from _________________ to _________________
Commission file number: 0-24260
--------
AMEDISYS, INC.
--------------------------------------------------
(Exact Name of Registrant as Specified in Charter)
Delaware 11-3131700
-------- ----------
(State or Other Jurisdiction of (I.R.S. Employer Identification No.)
Incorporation or Organization)
11100 Mead Road, Suite 300, Baton Rouge, LA 70816
-----------------------------------------------------------
(Address of principal executive offices including zip code)
(225) 292-2031
--------------
(Registrant's telephone number, including area code)
Indicate by check mark whether the issuer (1) has filed all reports required to
be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days. Yes[X] No[ ]
Number of shares of Common Stock outstanding as of August 13, 2002:
9,051,033 shares
1
PART I.
FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
Consolidated Balance Sheets as of June 30, 2002 and December 31, 2001........................... 3
Consolidated Statements of Operations for the Three and Six Months Ended
June 30, 2002 and 2001.......................................................................... 4
Consolidated Statements of Cash Flows for the Six Months Ended June 30, 2002 and 2001........... 5
Notes to Consolidated Financial Statements...................................................... 6
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS........... 14
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISKS..................................... 18
PART II.
OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS............................................................................... 19
ITEM 2. CHANGES IN SECURITIES........................................................................... 19
ITEM 3. DEFAULTS UPON SENIOR SECURITIES................................................................. 19
ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS............................................. 19
ITEM 5. OTHER INFORMATION............................................................................... 19
ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K................................................................ 19
2
ITEM 1. FINANCIAL STATEMENTS
AMEDISYS, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
AS OF JUNE 30, 2002 AND DECEMBER 31, 2001
(UNAUDITED, DOLLAR AMOUNTS IN 000'S)
June 30, 2002 December 31, 2001
----------------- -----------------
CURRENT ASSETS:
Cash and Cash Equivalents $ 9,921 $ 3,515
Patient Accounts Receivable, Net of Allowance for Doubtful Accounts
of $2,312 in June 2002 and $3,125 in December 2001 15,111 23,682
Prepaid Expenses 2,088 244
Deferred Income Taxes 1,965 --
Inventory and Other Current Assets 1,014 822
----------------- -----------------
Total Current Assets 30,099 28,263
Property and Equipment, net 9,363 10,290
Other Assets, net 24,169 22,301
----------------- -----------------
Total Assets $ 63,631 $ 60,854
================= =================
CURRENT LIABILITIES:
Accounts Payable $ 1,793 $ 2,440
Accrued Expenses:
Payroll and Payroll Taxes 6,330 6,798
Insurance 1,862 1,881
Income Taxes 1,034 930
Legal Settlements 974 1,227
Other 2,352 3,082
Notes Payable 457 9,305
Current Portion of Long-term Debt 3,798 5,355
Current Portion of Obligations under Capital Leases 2,358 2,391
Current Portion of Medicare Liabilities 6,146 13,214
----------------- -----------------
Total Current Liabilities 27,104 46,623
Long-term Debt 6,062 5,591
Obligations under Capital Leases 2,080 3,208
Long-term Medicare Liabilities 5,615 958
Deferred Income Taxes 1,134 --
Other Long-term Liabilities 1,016 1,099
----------------- -----------------
Total Liabilities 43,011 57,479
----------------- -----------------
Minority Interest in Consolidated Subsidiaries 66 66
----------------- -----------------
STOCKHOLDER'S EQUITY:
Common Stock (9,007,458 Shares in June 2002 and
7,178,152 Shares in December 2001) 9 7
Additional Paid-in Capital 28,120 16,539
Treasury Stock (4,167 Shares of Common Stock in
June 2002 and December 2001) (25) (25)
Retained Earnings (Deficit) (7,550) (13,212)
----------------- -----------------
Total Stockholder's Equity 20,554 3,309
----------------- -----------------
Total Liabilities and Stockholder's Equity $ 63,631 $ 60,854
================= =================
The accompanying notes are an integral part of these
consolidated financial statements.
3
AMEDISYS, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2002 AND 2001
(UNAUDITED, DOLLAR AMOUNTS IN 000'S, EXCEPT PER SHARE DATA)
Three months ended Six months ended
June 30, 2002 June 30, 2001 June 30, 2002 June 30, 2001
------------- ------------- ------------- -------------
Income:
Service revenue $ 32,854 $ 27,198 $ 64,704 $ 49,370
Cost of service revenue 14,573 12,157 28,442 21,924
------------- ------------- ------------- -------------
Gross Margin 18,281 15,041 36,262 27,446
------------- ------------- ------------- -------------
General and administrative expenses:
Salaries and benefits 9,637 7,560 19,068 14,202
Other 5,679 5,671 11,236 11,313
------------- ------------- ------------- -------------
Total general and administrative expenses 15,316 13,231 30,304 25,515
------------- ------------- ------------- -------------
Operating income 2,965 1,810 5,958 1,931
Other income and expense:
Interest income 24 99 42 254
Interest expense (420) (809) (998) (1,511)
Other income, net 77 79 208 96
------------- ------------- ------------- -------------
Total other expense, net (319) (631) (748) (1,161)
------------- ------------- ------------- -------------
Income before income taxes
and discontinued operations 2,646 1,179 5,210 770
Income tax expense (benefit) 986 -- (452) --
------------- ------------- ------------- -------------
Income before discontinued operations 1,660 1,179 5,662 770
Income (loss) from discontinued
operations, net of income taxes -- 78 -- (129)
------------- ------------- ------------- -------------
Net income $ 1,660 $ 1,257 $ 5,662 $ 641
============= ============= ============= =============
BASIC WEIGHTED AVERAGE COMMON SHARES OUTSTANDING
8,531 5,777 7,890 5,636
Basic income per common share:
Income before discontinued operations $ 0.19 $ 0.20 $ 0.72 $ 0.13
Income (loss) from discontinued
operations, net of income taxes -- 0.01 -- (0.02)
------------- ------------- ------------- -------------
Net income $ 0.19 $ 0.21 $ 0.72 $ 0.11
============= ============= ============= =============
DILUTED WEIGHTED AVERAGE COMMON SHARES
OUTSTANDING 9,112 7,920 8,493 7,750
Diluted income per common share:
Income before discontinued operations $ 0.18 $ 0.15 $ 0.67 $ 0.10
Income (loss) from discontinued
operations, net of income taxes -- 0.01 -- (0.02)
------------- ------------- ------------- -------------
Net income $ 0.18 $ 0.16 $ 0.67 $ 0.08
============= ============= ============= =============
The accompanying notes are an integral part of these
consolidated financial statements.
4
AMEDISYS, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE SIX MONTHS ENDED JUNE 30, 2002 AND 2001
(UNAUDITED, DOLLAR AMOUNTS IN 000'S)
Six months ended
June 30, 2002 June 30, 2001
------------- -------------
CASH FLOWS FROM OPERATING ACTIVITIES
Net Income $ 5,662 $ 641
Adjustments to reconcile net income to net cash provided (used)
by operating activities:
Depreciation and amortization 1,553 1,404
Provision for bad debts 1,384 949
Compensation expense -- 70
Deferred income taxes (831) --
Deferred revenue -- (1,059)
Other (94) --
Changes in assets and liabilities:
(Increase) in cash included in assets held for sale -- (52)
Decrease (increase) in accounts receivable 7,188 (9,529)
(Increase) in inventory and other current assets (1,967) (704)
(Increase) in other assets (38) (41)
(Decrease) increase in accounts payable (648) 1,000
Increase in accrued expenses 257 1,270
(Decrease) increase in Medicare liabilities (2,411) 4,650
(Decrease) in long-term liabilities (82) --
------------- -------------
Net cash provided (used) by operating activities 9,973 (1,401)
------------- -------------
CASH FLOWS FROM INVESTING ACTIVITIES:
Proceeds from sale of property and equipment 13 11
Purchase of property and equipment (569) (1,704)
Cash used in purchase acquisitions (875) (3,406)
Minority interest investment in subsidiary -- 33
------------- -------------
Net cash (used) by investing activities (1,431) (5,066)
------------- -------------
CASH FLOWS FROM FINANCING ACTIVITIES:
Net (repayments) borrowings on line of credit agreements (8,848) 4,207
Proceeds from issuance of notes payable and capital leases 446 73
Payments on notes payable and capital leases (3,652) (1,195)
Proceeds from private placement of stock, net 9,531 --
Proceeds from issuance of stock 387 239
------------- -------------
Net cash (used) provided by financing activities (2,136) 3,324
------------- -------------
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS 6,406 (3,143)
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD 3,515 6,967
------------- -------------
CASH AND CASH EQUIVALENTS AT END OF PERIOD $ 9,921 $ 3,824
============= =============
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Cash paid for:
Interest $ 925 $ 1,556
============= =============
Income taxes $ 354 $ 282
============= =============
The accompanying notes are an integral part of these
consolidated financial statements.
5
AMEDISYS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
1. ORGANIZATION
Amedisys, Inc. ("Amedisys" or "the Company") is a multi-state provider
of home health care nursing services. At June 30, 2002, the Company operated
fifty-seven home care nursing offices and two corporate offices in the southern
and southeastern United States.
In the opinion of management of the Company, the accompanying unaudited
consolidated financial statements contain all adjustments (consisting solely of
normal recurring adjustments) necessary to present fairly the Company's
financial position at June 30, 2002, the results of operations for the three and
six months ended June 30, 2002 and 2001, and cash flows for the six months ended
June 30, 2002 and 2001. The results of operations for the interim periods are
not necessarily indicative of results of operations for the entire year. These
interim consolidated financial statements should be read in conjunction with the
Company's annual financial statements and related notes in the Company's Form
10-K.
2. RECLASSIFICATION
The Company has reclassified Medicare liabilities due within one year
from a contra-asset account to a liability account in the accompanying
Consolidated Balance Sheets as of June 30, 2002 and December 31, 2001.
Previously, Medicare liabilities due within one year were netted against
accounts receivable. In the accompanying balance sheets, these liabilities are
reflected as Current Portion of Medicare Liabilities.
3. REVENUE RECOGNITION
Before implementation of the Medicare Prospective Payment System
("PPS") on October 1, 2000, reimbursement for home health care services to
patients covered by the Medicare program was based on reimbursement of allowable
costs subject to certain limits. Final reimbursement was determined after
submission of annual cost reports and audits thereof by the fiscal
intermediaries.
Under PPS, the Company is paid by Medicare based on episodes of care.
An episode of care is defined as a length of care up to sixty days with multiple
continuous episodes allowed. The standard episode payment beginning October 1,
2000 was established by the Medicare Program at $2,115 per episode, increased to
$2,274 per episode on October 1, 2001, to be adjusted by applicable regulations
including, but not limited to, the following: a case mix adjuster consisting of
eighty (80) home health resource groups ("HHRG"), the applicable geographic wage
index, low utilization, intervening events and other factors. The episode
payment will be made to providers regardless of the cost to provide care. The
services covered by the episode payment include all disciplines of care, in
addition to medical supplies, within the scope of the home health benefit.
Revenue is recognized as services are provided based on the number of patient
visits performed during the reporting period and a historical weighted average
revenue per visit, calculated as the estimated historical average final episode
payment divided by the historical average number of visits per episode.
6
4. EARNINGS PER SHARE
Earnings per common share are based on the weighted average number of
shares outstanding during the period. The following table sets forth the
computation of basic and diluted net income per common share for the three and
six month periods ended June 30, 2002 and 2001 including the results of
discontinued operations:
In 000's, except per share amounts
-------------------------------------------------------------
Three months Three months Six months Six months
ended ended ended ended
June 30, 2002 June 30, 2001 June 30, 2002 June 30, 2001
------------- ------------- ------------- -------------
Basic Net Income per Share:
Net Income $ 1,660 $ 1,257 $ 5,662 $ 641
============= ============= ============= =============
Weighted Average Number of
Shares Outstanding 8,531 5,777 7,890 5,636
============= ============= ============= =============
Net Income per Common
Share - Basic $ 0.19 $ 0.21 $ 0.72 $ 0.11
============= ============= ============= =============
Diluted Net Income per Share:
Net Income $ 1,660 $ 1,257 $ 5,662 $ 641
============= ============= ============= =============
Weighted Average Number of
Shares Outstanding 8,531 5,777 7,890 5,636
Effect of Dilutive Securities:
Stock Options 436 709 454 650
Warrants 145 260 149 245
Convertible Preferred Shares -- 1,174 -- 1,219
------------- ------------- ------------- -------------
Average Shares - Diluted 9,112 7,920 8,493 7,750
============= ============= ============= =============
Net Income per Common
Share - Diluted $ 0.18 $ 0.16 $ 0.67 $ 0.08
============= ============= ============= =============
5. MEDICARE REIMBURSEMENT AND REFORM
The Company derived approximately 89% of its revenues from continuing
operations from the Medicare system for the six months ended June 30, 2002 and
88% for the six months ended June 30, 2001.
On June 28, 2000, the Centers for Medicare & Medicaid Services ("CMS")
issued the final rules for PPS (as discussed in Note 3), which were effective
for all Medicare-certified home health agencies on October 1, 2000. The final
regulations establish payments based on episodes of care. An episode is defined
as a length of care up to sixty days with multiple continuous episodes allowed
under the rule. A standard episode payment was established at $2,115 per
episode, beginning October 1, 2000, to be adjusted by applicable regulations
including, but not limited to, the following: a case mix adjuster consisting of
eighty (80) home health resource groups ("HHRG"), the applicable geographic wage
index, low utilization, intervening events and other factors. Providers are
allowed to make a request for anticipated payment at the start of care equal to
60% of the expected payment for the initial episode and 50% for each subsequent
episode. The remaining balance due to the provider is paid following the
submission of the final claim at the end of the episode. In contrast to the
cost-based reimbursement system whereby providers' reimbursement was limited,
among other things, to their actual costs, episode payments are made to
providers regardless of the cost to provide care, except with regard to certain
outlier provisions. As a result, home health agencies have the opportunity to be
profitable under this system.
In December 2000, Congress passed the Benefits Improvement and
Protection Act ("BIPA"), which provides additional funding to health care
providers. BIPA provided for the following: (i) a one-year delay in applying the
budgeted 15% reduction on payment limits, (ii) the restoration of a full home
health market basket update for episodes ended on or after April 1, 2001, and
before October 1, 2001 resulting in an expected increase in revenues of 2.2%,
(iii) a
7
10% increase, effective April 1, 2001 and extending for a period of twenty four
months, for home health services provided in a rural area, and (iv) a one-time
payment equal to two months of periodic interim payments ("PIP").
Effective October 1, 2001, the standard episode payment for federal
fiscal year 2002 was increased to $2,274 per episode.
Currently, there is a budgeted 15% reduction in payment limits that
will be effective for patients on service or admitted beginning October 1, 2002.
Based on the complicated reimbursement formula and taking these reductions into
account, offset by an anticipated inflationary update with the beginning of the
new federal fiscal year, the anticipated annual reduction to service revenues
should approximate 5%. This budgeted reduction has been delayed for the past
three years and there is ongoing debate and discussion at the congressional
level concerning a further delay of the scheduled reduction, but there can be no
assurance that the scheduled reduction will not be implemented. In addition to
this scheduled reduction that will be effective October 1, 2002, the provision
in BIPA whereby home health providers received a 10% increase that began April,
2001 in reimbursement for serving patients in rural areas, which accounts for
approximately 30% of the Company's patient population, is scheduled to expire
March 31, 2003. In June 2002, the House of Representatives passed HR 4954, the
Medicare Modernization and Prescription Drug Act of 2002, which, among other
things, called for i) the elimination of the 15% reduction scheduled for October
1, 2002, ii) the extension through January 1, 2005 of the 10% rural payment
increase currently scheduled to expire in April 2003, and iii) setting the home
health market basket update for calendar year 2003 at 2%, for calendar year 2004
at 1.1%, and for calendar year 2005 at 2.7%. If any payment reductions take
place, the Company would reflect a decrease to service revenues which could be
material. The Company is currently evaluating its operations to increase
efficiencies and reduce costs in an effort to mitigate these impending
reductions.
6. ACQUISITIONS
Effective March 1, 2001, the Company acquired, through its wholly owned
subsidiary Amedisys Home Health, Inc. of Alabama, certain assets and liabilities
of Seton Home Health Services, Inc. ("Seton") from Seton Health Corporation of
North Alabama associated with its operations in Mobile and Fairhope, Alabama. In
consideration for the acquired assets and liabilities, the Company paid $440,000
cash, which represents a purchase price of $475,000 less the estimated value of
accrued vacation obligations. In connection with this acquisition, the Company
recorded $448,000 of goodwill.
Effective April 6, 2001, the Company acquired, through its wholly-owned
subsidiary Amedisys Home Health, Inc. of Alabama, certain additional assets and
liabilities of Seton from Seton Health Corporation of North Alabama associated
with its operations in Birmingham, Tuscaloosa, Anniston, Greensboro, and Reform,
Alabama. In consideration for the acquired assets and liabilities, the Company
paid $2,216,000 cash, which represents a purchase price of $2,325,000 less the
value of accrued vacation obligations. In connection with this acquisition, the
Company recorded $2,235,000 of goodwill.
Effective June 11, 2001, the Company acquired from East Cooper
Community Hospital, Inc. certain assets and liabilities of HealthCalls
Professional Home Health Services. In consideration for the acquired assets and
liabilities, the Company paid $750,000 cash. In connection with this
acquisition, the Company recorded $726,000 in goodwill.
Effective April 1, 2002, the Company, through its wholly-owned
subsidiary Amedisys Texas, Ltd., acquired certain assets and liabilities of
Christus Spohn Home Health Services from Christus Spohn Health System
Corporation ("Christus Spohn") associated with its operations in Corpus Christi,
Texas. The assets acquired consisted primarily of all furniture, fixtures,
equipment, leasehold improvements and supplies; inventory; all state home health
licenses and permits; the Medicare provider agreement; and the Medicaid provider
agreement. The liabilities assumed consisted of the accrued, but unused, paid
time off of the employees as well as the obligations accruing after April 1,
2002 relating to the conveyed contracts and agreements. Of the $1,875,000
purchase price given in consideration for the acquired assets and liabilities,
the Company paid $875,000 cash at closing and executed a promissory note in the
amount of $1,000,000 bearing interest at 7% annually and payable over a
three-year term in quarterly principal and interest installments of $93,000
beginning July 1, 2002. In connection with this acquisition, the Company
recorded $1,893,000 of goodwill in the second quarter of 2002.
8
7. DISCONTINUED OPERATIONS
During 1999, the Company changed its strategy from providing a variety
of alternate site provider health care services to becoming a leader in home
health care nursing services. Pursuant to this strategy, the Company divested
its non-home health care nursing divisions. The Company sold its six surgery
centers and sold or closed its four infusion locations with the final sale
taking place (as described below) in September, 2001.
Effective September 7, 2001, the Company, its wholly-owned subsidiary
Amedisys Surgery Centers, L.C., its 56% owned subsidiary Hammond Surgical Care
Center, L.C. d/b/a St. Luke's SurgiCenter ("St. Luke's"), and Surgery Center of
Hammond, L.L.C. ("Surgery Center") entered into an agreement for the purchase
and sale of the operations and assets of St. Luke's, an outpatient surgery
center located in Hammond, Louisiana, to Surgery Center. The sales price of
$2,850,000 was paid at closing and distributed in the following manner:
$1,066,000 paid directly to creditors of St. Luke's relating to existing debt
obligations, $1,684,000 paid to St. Luke's, and $100,000 in cash to be released
upon the determination of the value of working capital transferred.
Summarized financial information for the discontinued operations is as
follows (in 000's):
Three Months Six Months
ended ended
June 30, 2001 June 30, 2001
------------- -------------
Outpatient Surgery Division:
Service Revenue $ 744 1,282
Income from Discontinued
Operations Net of Income Taxes 78 4
Infusion Therapy Division:
Service Revenue $ -- --
(Loss) from Discontinued Operations
Net of Income Taxes -- (133)
Total Discontinued Operations:
Service Revenue $ 744 1,282
Income (Loss) from Discontinued
Operations Net of Income Taxes 78 (129)
8. NOTES PAYABLE
Notes payable as of June 30, 2002 consists primarily of an asset-based
line of credit with availability, depending on collateral, of up to $25 million
with National Century Financial Enterprises, Inc. ("NCFE") and borrowings under
a revolving bank line of credit of up to $2.5 million. The $25 million
asset-based line of credit, which matures June, 2005, is collateralized by
eligible accounts receivable and as of June 30, 2002 and December 31, 2001, had
an outstanding balance of $457,000 and $8,593,000, respectively. There was $6.5
million available under this line as of June 30, 2002 and no amounts available
as of December 31, 2001. Eligible receivables are defined as receivables,
exclusive of workers' compensation and self-pay, that are aged less than 181
days. The effective interest rate on this line of credit was 8.91% and 11.00%
for the six months ended June 30, 2002 and the year ended December 31, 2001,
respectively. The revolving bank line of credit of $2.5 million bears interest
at the Bank One Prime Floating Rate, which was 4.75% at June 30, 2002 and
December 31, 2001. At June 30, 2002, there were no amounts drawn on the bank
line of credit with $2,500,000 available. At December 31, 2001, there was
$712,000 drawn on the line of credit with $1,788,000 available.
9
9. LONG-TERM DEBT
Long-term debt as of June 30, 2002 consists primarily of a $7.1 million
note payable to NPF Capital, a $547,000 note payable to CareSouth Home Health
Services, Inc. ("CareSouth"), a $486,000 note payable to Winter Haven Hospital,
and a $1.0 million note payable to Christus Spohn (See note 6).
The $7.1 million note to NPF Capital was restructured during June 2002
to extend the maturity to June 2005 with revised monthly principal and interest
payments of $211,000 at an interest rate equal to the prime rate, 4.75% at June
30, plus 3.25%. The Company makes monthly principal and interest payments of
$25,000 on the $547,000 note to CareSouth, which is due May 2004, monthly
principal and interest payments of $30,000 on the $486,000 note to Winter Haven
Hospital, which is due November 2003 and quarterly principal and interest
payments of $93,000 on the $1.0 million note to Christus Spohn, which is due
April 2005.
10. CAPITAL LEASES
Capital leases consist primarily of a Software License Agreement with
CareSouth and an equipment lease agreement with Cisco Systems Capital
Corporation ("Cisco"). The CareSouth lease requires monthly payments of $178,000
and had an outstanding balance of $3,727,000 at June 30, 2002. This agreement
contains a bargain purchase option that the Company intends to exercise upon
expiration of the agreement in May 2004. The Cisco capital lease, secured by
equipment used currently in connection with the Company's wide-area network,
requires monthly payments of $21,000 and had a balance of $464,000 at June 30,
2002. This lease expires July 2004.
11. AMOUNTS DUE TO MEDICARE
As of June 30, 2002, the Company estimates an aggregate payable to
Medicare of $11.8 million resulting from interim cash receipts in excess of
expected reimbursement. Included in this figure is $7.4 million attributed to a
provision in BIPA whereby a lump-sum payment equal to two months of PIP was
advanced to providers. The fiscal year ending December 31, 2000 cost reports,
which reflected the BIPA payments, were filed in June 2002 and July 2002. In
June 2002, CMS issued a Program Memorandum granting automatic thirty-six month
repayment plans for providers who received the BIPA payment if five specific
criteria are met. The Company believes that it meets the criteria and has begun
receiving formal notification of thirty-six month repayment plans for some
agencies, the remainder of which we believe will commence no later than October
2002. Accordingly, in the accompanying Consolidated Balance Sheet as of June 30,
2002, the Company has classified the BIPA overpayments appropriately between
Current Portion of Medicare Liabilities and Long-term Medicare Liabilities. The
amounts due to Medicare within one year of $6.2 million are shown as Current
Portion of Medicare Liabilities and the amount payable to Medicare in excess of
one year of $5.6 million is shown as Long-term Medicare Liabilities. Included in
the Current Portion of Medicare Liabilities figure of $6.2 million is a $3.1
million overpayment relating to Alliance Home Health, a wholly owned subsidiary
of the Company which filed for bankruptcy protection on September 29, 2000 and
for which no payments are currently being made.
12. INCOME TAXES
The Company files a consolidated federal income tax return that
includes all subsidiaries that are more than 80% owned. State income tax returns
are filed individually by the subsidiaries in accordance with state statutes.
The Company uses the asset and liability approach to measuring deferred
tax assets and liabilities based on temporary differences existing at each
balance sheet date using currently enacted tax rates in accordance with
Statement of Financial Accounting Standards No. 109 ("SFAS 109"), Accounting for
Income Taxes. Deferred tax assets are reduced by a valuation allowance when, in
the opinion of management, it is more likely than not that some portion of the
deferred tax assets will not be realized. As of December 31, 2001, the Company
had a recorded valuation allowance of $2,587,000. Management of the Company
determined, based on the first quarter 2002 operating results and projections
for fiscal year 2002, that it was more likely than not that the Company would be
able to use all of the previously unrecognized tax benefits. Accordingly, in the
quarter ended March 31, 2002, the Company recorded a tax benefit of $1,438,000
resulting primarily from elimination of all of the valuation allowance. For the
quarter ended June 30, 2002, the Company recorded income tax expense of
$986,000, an effective rate of 37%.
10
Total income tax expense included in the accompanying Consolidated
Statements of Operations is as follows (in 000's):
Three Months ended Six Months ended
June 30, June 30,
------------------- --------------------
2002 2001 2002 2001
-------- -------- -------- --------
Current income tax expense $ 299 $ -- $ 379 $ --
Deferred income tax benefit 687 -- (831) --
-------- -------- -------- --------
Total income tax $ 986 $ -- $ (452) $ --
======== ======== ======== ========
Total tax expense on income before taxes resulted in effective tax
rates that differed from the federal statutory income tax rate. A reconciliation
of these rates is as follows as of June 30, 2002:
Three Months Six Months
ended ended
June 30, 2002 June 30, 2002
------------- -------------
Income taxes computed on federal statutory rate 35% 35%
State income taxes and other 2 5
Removal of valuation allowance -- (50)
Nondeductible expenses and other -- 1
------------- -------------
Total 37% (9)%
============= =============
Net deferred tax assets consist of the following components as of June
30, 2002 and December 31, 2001 (in 000's):
June 30, December 31,
2002 2001
------------- -------------
Deferred tax assets:
NOL carryforward $ -- $ 1,066
Allowance for doubtful accounts 595 847
Property and equipment 422 371
Self-insurance reserves 654 618
Losses of consolidated subsidiaries not consolidated
for tax purposes, expiring beginning in 2010 144 144
Expenses not currently deductible for tax purposes 466 606
Other 106 100
Deferred tax liabilities:
Amortization of intangible assets (1,556) (1,165)
Less: Valuation allowance -- (2,587)
------------- -------------
$ 831 $ --
============= =============
13. EFFECT OF NEW FINANCIAL ACCOUNTING STANDARDS
In July 2001, the Financial Accounting Standards Board ("FASB") issued
Financial Accounting Standards Statement No. 141, Business Combinations ("SFAS
141") and Financial Accounting Standards Statement No. 142, Goodwill and Other
Intangible Assets ("SFAS 142"). SFAS 141 eliminates the pooling-of-interests
method of accounting for business combinations except for qualifying business
combinations that were initiated prior to July 1, 2001. The purchase method of
accounting is required to be used for all business combinations initiated after
June 30, 2001. SFAS 141 also requires separate recognition of intangible assets
that meet certain criteria.
Under SFAS 142, goodwill and indefinite-lived intangible assets are no
longer amortized but are reviewed for impairment annually, or more frequently if
circumstances indicate potential impairment. Separable intangible assets that
11
are not deemed to have an indefinite life will continue to be amortized over
their useful lives. For goodwill and indefinite-lived intangible assets acquired
prior to July 1, 2001, goodwill was amortized through 2001, at which time
amortization ceased and a transitional goodwill impairment test was performed.
The Company adopted SFAS 142 effective January 1, 2002. Management has evaluated
the impact of the new accounting standards on existing goodwill and other
intangible assets and has concluded that no impairment exists as of June 30,
2002. Included in general and administrative expenses in the accompanying
Consolidated Statements of Operations is goodwill amortization expense as
follows (in 000's):
Three Months ended Six Months ended
June 30, June 30,
--------------------- ---------------------
2002 2001 2002 2001
--------- --------- --------- ---------
Goodwill Amortization Expense $ -- $ 314 $ -- $ 594
In July 2001, the FASB issued SFAS No. 143, "Accounting for Asset
Retirement Obligations," which requires recording the fair value of a liability
for an asset retirement obligation in the period incurred. The standard is
effective for fiscal years beginning after June 15, 2002, with earlier
application permitted. Upon adoption of the standard, the Company will be
required to use a cumulative effect approach to recognize transition amounts for
any existing retirement obligation liabilities, asset retirement costs and
accumulated depreciation. The Company does not have any asset retirement
obligations; therefore, adoption of this statement will not have an effect on
the Company's financial statements.
In August 2001, the FASB issued SFAS No. 144, "Accounting for the
Impairment or Disposal of Long-Lived Assets" ("SFAS 144"), which supersedes FASB
Statement No. 121, "Accounting for the Impairment of Long-Lived Assets and for
Long-Lived Assets to be Disposed of". This new statement also supersedes certain
aspects of APB 30, "Reporting the Results of Operations-Reporting the Effects of
Disposal of a Segment of a Business, and Extraordinary, Unusual and Infrequently
Occurring Events and Transactions", with regard to reporting the effects of a
disposal of a segment of a business and will require expected future operating
losses from discontinued operations to be reported in discontinued operations in
the period incurred rather than as of the measurement date as presently required
by APB 40. Additionally, certain dispositions may now qualify for discontinued
operations treatment. The provisions of this statement are required to be
applied for fiscal years beginning after December 15, 2001 and interim periods
within those fiscal years. The Company adopted SFAS 144 effective January 1,
2002. The adoption of SFAS 144 did not have any effect on the Company's
financial statements.
In April 2002, the FASB issued SFAS No. 145, "Rescission of FASB
Statements No. 4, 44, and 64, Amendment of FASB Statements No. 13 and Technical
Corrections" ("SFAS 145"). SFAS 145 provides guidance for income statement
classification of gains and losses on extinguishments of debt and accounting for
certain lease modifications that have economic effects that are similar to
sale-leaseback transactions. SFAS 145 is effective for the Company in January
2003. The Company is evaluating the impact of SFAS 145 and believes it will not
have a material effect on the Company's financial statements.
In June 2002, the FASB issued SFAS No. 146, "Accounting for Exit or
Disposal Activities" ("SFAS 146"). SFAS 146 addresses significant issues
regarding the recognition, measurement, and reporting of costs that are
associated with exit and disposal activities, including restructuring activities
that are currently accounted for pursuant the guidance set forth in EITF Issue
No. 94-3, "Liability Recognition of Certain Employee Termination Benefits and
Other Costs to Exit an Activity". SFAS 146 is effective for the Company in
January 2003. The Company is evaluating the impact of SFAS No. 146 and believes
it will not have a material effect on the Company's financial statements.
12
14. GOODWILL AND OTHER INTANGIBLE ASSETS
In accordance with SFAS 142, the Company discontinued the
amortization of goodwill effective January 1, 2002. A reconciliation of
previously reported net income and earnings per share to the amounts adjusted
for the exclusion of goodwill amortization, net of tax, follows (in 000s, except
per share data):
Three Months ended Six Months ended
June 30, June 30,
------------------------- -------------------------
2002 2001 2002 2001
----------- ----------- ----------- -----------
Net income, as reported $ 1,660 $ 1,257 $ 5,662 $ 641
Add: Goodwill amortization, net of tax -- 314 -- 594
----------- ----------- ----------- -----------
Adjusted net income $ 1,660 $ 1,571 $ 5,662 $ 1,235
=========== =========== =========== ===========
Basic income per share:
Reported net income $ 0.19 $ 0.21 $ 0.72 $ 0.11
Goodwill amortization -- 0.06 -- 0.11
----------- ----------- ----------- -----------
Adjusted net income $ 0.19 $ 0.27 $ 0.72 $ 0.22
=========== =========== =========== ===========
Diluted income per share:
Reported net income $ 0.18 $ 0.16 $ 0.67 $ 0.08
Goodwill amortization -- 0.04 -- 0.08
----------- ----------- ----------- -----------
Adjusted net income $ 0.18 $ 0.20 $ 0.67 $ 0.16
=========== =========== =========== ===========
Changes in the carrying amount of goodwill for the six month period
ended June 30, 2002 are as follows (in 000s):
Balance as of December 31, 2001 $ 22,216
Goodwill acquired in the six months ended June 30,
2002 (See Note 6) 1,893
-------------
Balance as of June 30, 2002 $ 24,109
=============
15. PRIVATE PLACEMENT OF COMMON STOCK
On April 26, 2002, the Company completed a private placement of
1,460,000 shares of Common Stock with private investors at a price of $6.94 per
share. This placement provided net proceeds to the Company of approximately $9.5
million. The Company intends to use the proceeds for both debt reduction and
general corporate purposes, including possible acquisitions. The Company engaged
Belle Haven Investments, L.P. ("BHI") and Sanders Morris Harris ("Sanders") as
placement agents for this transaction pursuant to which BHI received $544,300 in
cash and BHI and its principals received warrants to purchase up to 64,500
shares of common stock exercisable at $8.12 per share and Sanders received
$15,615 in cash and warrants to purchase up to 4,500 shares of common stock
exercisable at $8.12 per share.
13
16. STOCKHOLDERS' EQUITY
The following table summarizes the activity in Stockholders' Equity
for the six months ended June 30, 2002
(in 000's, except share information):
Common Common Additional Retained Total
Stock Stock Paid-in Treasury Earnings Stockholders'
Shares Amount Capital Stock (Deficit) Equity
------------- ------------- ------------- ------------- ------------- -------------
Balance, December 31, 2001 7,178,152 $ 7 $ 16,539 $ (25) $ (13,212) $ 3,309
Issuance of stock for
Employee Stock Purchase Plan 67,423 -- 368 -- -- 368
Issuance of stock for 401k
match 191,713 1 1,295 -- -- 1,296
Exercise of stock options 110,170 -- 387 -- -- 387
Issuance of stock relating to
private placement 1,460,000 1 9,531 -- -- 9,532
Net income -- -- -- -- 5,662 5,662
------------- ------------- ------------- ------------- ------------- -------------
Balance, June 30, 2002 9,007,458 $ 9 $ 28,120 $ (25) $ (7,550) $ 20,554
============= ============= ============= ============= ============= =============
17. CHANGE IN INDEPENDENT AUDITORS
On April 30, 2002, the Board of Directors of the Company, upon
recommendation of the Audit Committee, dismissed Arthur Andersen LLP
("Andersen") as the Company's independent auditors. A Form 8-K was filed with
the SEC on May 3, 2002 and a Form 8-K/A was filed with the SEC on May 13, 2002
relating to this matter. Also effective April 30, 2002, the Board of Directors,
upon recommendation of the Audit Committee, selected KPMG LLP ("KPMG") to serve
as the Company's independent auditors for 2002. At that time, the definitive
engagement of KPMG was contingent upon the completion of KPMG's standard client
evaluation procedures. These procedures were completed on May 24, 2002 and a
Form 8-K/A was filed with the SEC on May 24, 2002 detailing such.
18. SUBSEQUENT EVENTS
Effective August 1, 2002, the Company, through its wholly-owned
subsidiary Amedisys Texas, Ltd., acquired certain assets and liabilities of
Baylor All Saints Medical Center and All Care, Inc. associated with their home
health care operations in Fort Worth, Texas. The assets acquired consisted of
furniture, fixtures, and equipment; inventory; licenses and permits, to the
extent assignable, including the Medicare and Medicaid provider numbers; and
goodwill. The liabilities assigned consisted of the accrued, but unused, paid
time off of the employees as well as the obligations accruing on or after August
1, 2002 relating to the assumed contracts and agreements. In consideration for
the acquired assets and liabilities, the Company paid $1,000,000 cash at closing
and executed a promissory note in the amount of $200,000 for a total purchase
price of $1,200,000. The promissory note, bearing interest at 7% per annum, is
payable in quarterly principal and interest installments beginning November
2002. In connection with this acquisition, the Company will record approximately
$1,190,000 of goodwill in the third quarter of 2002.
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF OPERATIONS
The following discussion and analysis provides information which
management believes is relevant to an assessment and understanding of the
Company's results of operations and financial condition. This discussion should
be read in conjunction with the Consolidated Financial Statements and Notes
thereto and the related Management's Discussion and Analysis in the Company's
Form 10-K for the year ended December 31, 2001.
14
RESULTS OF OPERATIONS
Service Revenues. Net revenues increased $5,656,000 or 21% for the
three months ended June 30, 2002 and $15,334,000 or 31% for the six months ended
June 30, 2002, as compared to the same periods in 2001. For the three months
ended June 30, 2002 as compared to the same period in 2001, this increase was
attributed to an increase in patient admissions and the per episode Medicare
reimbursement increase effective October 1, 2001. Patient admissions increased
971 or 10% from 9,575 for the three months ended June 30, 2001 to 10,546 for the
comparable period of 2002. This quarter to quarter increase in admissions is
attributable to both internal growth and acquisitions with full operations
during the quarter ended June 30, 2002. For the six months ended June 30, 2002
as compared to the same period in 2001, the increase in service revenues was
attributed, as well, to an increase in patients admissions and the per episode
Medicare reimbursement increase effective October 1, 2001 and April 1, 2001. For
the comparable six month periods, patient admissions increased by 3,652 or 21%
from 17,520 for the six months ended June 30, 2001 to 21,172 for the same period
of 2002. This increase in patient admissions was derived from both internal
growth and acquisitions completed during the 2nd quarter of 2001 and 2002.
Cost of Revenues. Cost of revenues increased 20% and 30% for the three
and six months ended June 30, 2002 as compared to the same periods in 2001.
These increases are attributed to an increase in patient visits and increased
salaries for the clinical manager positions. Patient visits increased 16,985 or
7%, from 258,855 for the three months ended June 30, 2001 to 275,840 for the
three months ended June 30, 2002. For the six month period comparison, patient
visits increased 79,544 or 17% from 467,100 for the six months ended June 30,
2001 to 546,644 for the six months ended June 30, 2002. Salaries for the
clinical manager positions increased $558,000 and $1,304,683 for the three and
six months ended June 30, 2002 as compared to the same periods in 2001. The
clinical manager position was implemented company-wide in the latter part of
2000, with full staffing completed during 2001, to provide a greater level of
patient care oversight and coordination.
General and Administrative Expenses ("G&A"). G&A increased $2,085,000,
or 16%, for the three months ended June 30, 2002 and $4,789,000, or 19%, for the
six months ended June 30, 2002 as compared to the same periods in 2001. As a
percentage of net revenues, G&A decreased 2% and 5% for the three and six months
ended June 30, 2002, respectively, as compared to the same periods in 2001. This
dollar increase from the three month period ended June 30, 2001 as compared to
the same period of 2002 is primarily attributed to increased G & A for
acquisitions of $462,000, increased health insurance costs of $613,000,
increased depreciation expense in connection with the installation of the
wide-area network during the latter part of 2001, and additional personnel costs
in several corporate departments including billing and information services,
offset by a decrease in goodwill amortization expense. For the six month period
ended June 30, 2001 as compared to the same period of 2002, the increase is
primarily attributed to increased G & A for acquisitions of $1.3 million,
increased health insurance costs of $1,260,000, and the similar increases in
depreciation expense and personnel costs as noted above, offset by a decrease in
goodwill amortization expense.
Other Income and Expense. Other income and expense decreased $312,000
or 49% and $413,000 or 35% for the three and six months ended June 30, 2002 as
compared to the same periods in 2001. This decrease is primarily attributed to
lower interest expense incurred during both respective periods of 2002 as result
of the Company's improved cash collections and corresponding decrease in funding
through the lines of credit.
Income Tax Expense. Income tax expense (benefit) of $986,000 and
($452,000) was recorded for the three months and six months ended June 30, 2002.
An effective income tax rate of 37% was recorded on income before taxes during
both the three and six month periods ended June 30, 2002. Additionally, an
income tax benefit of $2,587,000 was recorded primarily from elimination of all
of the valuation allowance for net deferred tax assets at March 31, 2002.
CRITICAL ACCOUNTING POLICIES
The financial statements are prepared in accordance with generally
accepted accounting principles and include amounts based on management's
judgements and estimates. These judgements and estimates are based on, among
other things, historical experience and information available from outside
sources. The critical accounting policies presented below have been discussed
with the Audit Committee as to the development and selection of the accounting
estimates used as well as the disclosures provided herein. Actual results could
differ materially from these estimates.
MEDICARE REVENUE RECOGNITION
The Company derived approximately 89% of net service revenue from the
Medicare system for the six months ended June 30, 2002. Under PPS, the Company
is paid by Medicare based on episodes of care. An episode of care is defined as
a length of care up to sixty days with multiple continuous episodes allowed. The
standard episode payment beginning October 1, 2000 was established by the
Medicare Program at $2,115 per episode, to be adjusted by applicable
regulations including, but not limited to, the following: a case mix adjuster
consisting of eighty (80) home health resource groups ("HHRG"), the applicable
geographic wage index, low utilization, intervening events and other factors.
15
Effective October 1, 2001, the standard episode payment was increased, through
federal legislation, to $2,274 per episode. Revenue is recognized as services
are provided based on the number of patient visits performed during the
reporting period and a historical weighted average revenue per visit, calculated
as the estimated historical average final episode payment divided by the
historical average number of visits per episode. Any significant change in the
current case mix of patients, geographic distribution of patients, or
utilization of services could produce a variance to service revenue that differs
materially from the revenue recorded based on historical information.
Prior to the implementation of PPS on October 1, 2000, Medicare revenue
was based on allowable costs subject to certain limits. Final reimbursement was
determined after submission of annual cost reports and audits thereof by the
fiscal intermediaries. In 1997, Congress approved the Balanced Budget Act of
1997 (the "Budget Act"). The Budget Act established an interim payment system
(the "IPS") that provided for the lowering of reimbursement limits for home
health visits until PPS was implemented. For cost reporting periods beginning on
or after October 1, 1997, Medicare-reimbursed home health agencies cost limits
were determined as the lesser of (i) their actual costs, (ii) per visit cost
limits based on 105% of median costs of freestanding home health agencies, or
(iii) a per beneficiary limit determined for each specific agency. The IPS cost
limits applied to the Company for the cost reporting period beginning January 1,
1998 and remained in effect until October 1, 2000.
NON-MEDICARE REVENUE RECOGNITION
The Company derived approximately 11% of net service revenue from
non-Medicare payor sources for the six months ended June 30, 2002. Non-Medicare
payor sources reimburse the Company for services provided under both
fee-for-service arrangements and capitated arrangements. Under fee-for-service
arrangements, net service revenues are recorded at the expected realizable
amount in the reporting period in which the service is provided. The expected
realizable amount is determined using the contractual reimbursement rates on a
per payor, per discipline basis if available, or historical experience. Under
capitated arrangements, net service revenues are recorded at the predetermined
monthly per member per month rate irrespective of the services performed.
COLLECTIBILITY OF ACCOUNTS RECEIVABLE
The process for estimating the ultimate collectibility of accounts
receivable involves judgement, primarily relating to non-Medicare accounts
receivable. The Company currently records an allowance for uncollectible
accounts on a percentage of revenues basis unless a specific issue is noted, at
which time an additional allowance may be recorded.
FINANCIAL CONDITION
The Company recorded operating losses and had negative cash flow for
the year ended December 31, 1999 and the first three quarters of 2000, during
which time its operations were primarily funded by the divestiture of certain
non-core assets. The significant losses and negative cash flow from operations
were largely attributable to the prior Medicare reimbursement system which was
effective from January 1, 1998 through October 1, 2000 for the Company.
Beginning in October 2000 through the end of the first quarter of 2001, the
Company reported positive cash flow and a decrease in operating losses primarily
as a result of the implementation of PPS on October 1, 2000. Beginning in the
second quarter of 2001 and through this quarter ending June 30, 2002, the
Company has reported profitability and positive cash flow due, in part, to per
episode Medicare reimbursement increases effective April 1, 2001 and October 1,
2001. Absent any material acquisition, the Company anticipates positive cash
flow from operations will continue throughout 2002.
As described in Note 15 to the Consolidated Financial Statements, the
Company completed a private placement of common stock during April 2002
resulting in net proceeds to the Company of approximately $9.5 million for which
the Company intends to use for both debt reduction and general corporate
purposes, including possible acquisitions.
The Company also has certain contingencies recorded as current
liabilities in the accompanying Consolidated Balance Sheets (in accordance with
SFAS No. 5) that management does not believe will currently impact cash flow.
Also, as discussed in Note 8, the Company has available $9.0 million under the
NCFE and bank lines of credit which would be available to fund working capital
needs.
The following table summarizes the Company's current contractual
obligations (in 000's):
16
Payments Due by Period
----------------------------------------------------------
Contractual
Obligations Total Less than 1 year 1-3 years 4-5 years
----------- ----------- ---------------- ----------- -----------
Notes Payable (Note 8) $ 457 $ 457 $ -- $ --
Long-Term Debt (Note 9) 9,860 3,798 6,062 --
Capital Lease Obligations
(Note 10) 4,438 2,358 2,079 1
Medicare Liabilities
(Note 11) 11,761 6,146 5,615 --
----------- ----------- ----------- -----------
Total Contractual Cash
Obligations $ 26,516 $ 12,759 $ 13,756 $ 1
=========== =========== =========== ===========
The Company's operating activities provided $9,973,000 in cash during
the six months ended June 30, 2002, whereas such activities used $1,401,000 in
cash during the six months ended June 30, 2001. Cash provided by operating
activities in 2002 is primarily attributable to net income of $5,662,000, net
non-cash items such as depreciation and amortization of $1,553,000, provision
for bad debts of $1,384,000, an increase in deferred tax assets of ($831,000),
other of ($94,000), and changes in assets and liabilities of $2,299,000.
Investing activities used $1,431,000 for the six months ended June 30, 2002,
whereas such activities used $5,066,000 for the six months ended June 30, 2001.
Cash used by investing activities in 2002 is attributed to the purchase of
property and equipment of $569,000 and cash used in acquisitions of $875,000,
offset by proceeds from the sale of property and equipment of $13,000. Financing
activities used cash during the six months ended June 30, 2002 of $2,136,000,
whereas such activities provided $3,324,000 during the same period in 2001. Cash
used by financing activities in 2002 is primarily attributed to proceeds from a
private placement of stock of $9,531,000, issuance of notes payable and capital
leases of $446,000, and proceeds from the issuance of stock of $387,000, offset
by repayments on line of credit agreements of $8,848,000 and payments on notes
payable and capital leases of $3,652,000.
The Company derived approximately 89% of its service revenues from the
Medicare system for the six months ended June 30, 2002. Currently, there is a
budgeted 15% reduction in payment limits that will be effective for patients on
service or admitted beginning October 1, 2002. Based on the complicated
reimbursement formula and taking these reductions into account, offset by an
anticipated inflationary update with the beginning of the new federal fiscal
year, the anticipated reduction to service revenues should approximate 5%. This
budgeted reduction has been delayed for the past three years and there is
ongoing debate and discussion at the congressional level concerning scheduled
reduction, but there can be no assurance that the scheduled reduction will not
be implemented. In addition to this scheduled reduction that will be effective
October 1, 2002, the provision in BIPA whereby home health providers received a
10% increase in reimbursement for serving patients in rural areas, which
accounts for approximately 30% of the Company's patient population, is scheduled
to expire March 31, 2003. In June 2002, the House of Representatives passed HR
4954, the Medicare Modernization and Prescription Drug Act of 2002, which, among
other things, called for i) the elimination of the 15% reduction scheduled for
October 1, 2002, ii) the extension through January 1, 2005 of the 10% rural
payment increase currently scheduled to expire in April 2003, and iii) setting
the home health market basket update for calendar year 2003 at 2%, for calendar
year 2004 at 1.1%, and for calendar year 2005 at 2.7%. In the event that any
payment reductions take place, the Company would reflect a decrease to service
revenues which could be material. The Company is currently evaluating its
operations to increase efficiencies and reduce costs in an effort to mitigate
these impending reductions.
In 1999, the Company discovered questionable conduct involving the
former owner of its Monroe, Louisiana, agency. The Company conducted an initial
audit (using an independent auditor) and voluntarily disclosed the
irregularities to the Department of Health and Human Services' Office of the
Inspector General. Since that time, the government has been examining the
disclosed activities and during the second quarter of 2002, a further audit of
relevant claims was initiated at the request of the government, which is
currently ongoing. Management believes the Company has adequately reserved for
the estimated liability associated therewith; but no assurances can be provided
that the ultimate resolution will not be materially different than the current
estimate.
From December 31, 1998 to November 9, 2000, the Company was covered by
Reliance
17
Insurance Company of Illinois ("Reliance") for risks associated with
professional and general liability. The Company became aware of the
deteriorating stability and rating of Reliance during the latter part of 2000
and thus, secured coverage with another insurer on November 9, 2000 for
occurrences after that date. Reliance is currently in liquidation and may not be
in a position to pay or defend claims incurred by the Company during the period
stated above. The Company has several open claims relating to this period above
for which it is now defending and does not believe that the ultimate resolution
of these claims will be materially different from reserves established for those
claims. The Company is unaware of, and does not expect, any material claims that
may be made based on occurrences during the period, but there is no assurance
that additional claims will not be brought against the Company relating to
incidents which occurred during the time period stated above or that any such
claims will not be material.
Towards the end of our second quarter and continuing through July, the
Company has experienced a slowdown in admission growth in certain markets. In
response to this issue, management has completed a realignment of the sales
organization, which we believe will address this slowdown and contribute to the
ongoing growth and vitality of Amedisys, Inc. However, should this trend
continue, it would have an impact on the internal growth rate and on future
operating results.
The Company does not believe that inflation has had a material effect
on its results of operations for the three and six month periods ended June 30,
2002.
ARTHUR ANDERSEN LLP
Our financial statements for the year ended December 31, 2001 were
audited by Arthur Andersen LLP ("Andersen"), our former independent accountants.
On June 15, 2002, a jury convicted Andersen on obstruction of justice charges,
and Andersen has announced that unless the jury verdict is set aside, a
judgement of conviction could be entered as early as August 31, 2002, which will
effectively end the firm's audit practice. Should we seek access to the public
capital markets in the future, SEC rules will require us to include or
incorporate by reference in any prospectus three years of audited financial
statements. Until our audited financial statements for the fiscal year ending
December 31, 2004 become available in the first quarter of 2005, the SEC's
current rules would require us to present audited financial statements for one
or more fiscal years audited by Andersen. Before then, the SEC may cease
accepting financial statements audited by Andersen, in which case we would be
unable to access the public capital market unless KPMG LLP, our current
independent accounting firm, or another independent accounting firm, is able to
audit the financial statements originally audited by Andersen. Following the
conviction of Andersen, the SEC issued a release stating that Andersen has
informed the SEC that it will cease practicing before the SEC by August 31,
2002, unless the SEC determines another date is appropriate. Although the SEC
has indicated that in the interim it will continue to accept financial
statements audited by Andersen, there is no assurance that the SEC will continue
to do so in the future.
FORWARD LOOKING STATEMENTS
When included in the Quarterly Report on Form 10-Q or in documents
incorporated herein by reference, the words "expects", "intends", "anticipates",
"believes", "estimates", and analogous expressions are intended to identify
forward-looking statements. Such statements inherently are subject to a variety
of risks and uncertainties that could cause actual results to differ materially
from those projected. Such risks and uncertainties include, among others,
general economic and business conditions, current cash flows and operating
deficits, debt service needs, adverse changes in federal and state laws relating
to the health care industry, competition, regulatory initiatives and compliance
with governmental regulations, customer preferences and various other matters,
many of which are beyond the Company's control. These forward-looking statements
speak only as of the date of the Quarterly Report on Form 10-Q. The Company
expressly disclaims any obligation or undertaking to release publicly any
updates or any changes in the Company's expectations with regard thereto or any
changes in events, conditions or circumstances on which any statement is based.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISKS
The Company does not engage in derivative financial instruments, other
financial instruments, or derivative commodity instruments for speculative or
trading/non-trading purposes.
18
PART II. OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
None.
ITEM 2. CHANGES IN SECURITIES
On April 26, 2002, the Company completed a private placement of
1,460,000 shares of Common Stock. The Common Stock was sold to accredited
investors at a cash price of $6.94 per share for gross proceeds of $10,132,400.
This placement provided net proceeds to the Company of approximately $9.5
million. The Company engaged Belle Haven Investments, L.P. ("BHI") and Sanders
Morris Harris ("Sanders") as placement agents for this transaction. BHI
received $544,300 in cash commissions and BHI and its principals received
warrants to purchase up to 64,500 shares of common stock exercisable at $8.12
per share. Sanders received $15,615 in cash commissions and warrants to
purchase up to 4,500 shares of common stock exercisable at $8.12 per share. All
the warrants issued to the placement agents pursuant to this transaction have
an exercise price of $8.12 per share and are exercisable beginning on the
six-month anniversary of the transaction and until the five-year anniversary of
the transaction. The Company relied primarily on the exemption from federal
registration provided by Section 4(2) of the Securities Act of 1933 and Rule
506 of Regulation D by privately offering the securities to accredited
investors.
ITEM 3. DEFAULTS UPON SENIOR SECURITIES
None.
ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
The annual shareholders' meeting of the Company was held on June 13,
2002 for election of five directors to serve until the next annual meeting of
the shareholders of the Company. The nominated individuals were William F.
Borne, CEO of Amedisys, Inc.; Ronald A. LaBorde, President and CEO of Piccadilly
Cafeterias, Inc.; Jake L. Netterville, Chairman of the Board of Directors of
Postlethwaite and Netterville, a professional accounting firm; David R. Pitts,
President and CEO of Pitts Management Associates, Inc.; and Peter F. Ricchiuti,
Assistant Dean and Director of Research of BURKENROAD Reports at Tulane
University's A.B. Freeman School of Business. These individuals were elected
with the following votes:
Director Votes in Favor Votes Withheld
--------- -------------- --------------
Mr. Borne 6,664,596 6,910
Mr. LaBorde 6,664,596 6,910
Mr. Netterville 6,664,596 6,910
Mr. Pitts 6,664,596 6,910
Mr. Ricchiuti 6,664,596 6,910
ITEM 5. OTHER INFORMATION
None.
ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K
(a) Exhibits
Exhibit
No. Identification of Exhibit
------- -------------------------
3.1(4) - Certificate of Incorporation
3.2(3) - Bylaws
4.2(1) - Common Stock Specimen
4.7(2) - Shareholder Rights Agreement
10.1(5) - Employment Agreement between Amedisys, Inc. and Greg Browne
21.1(1) - List of Subsidiaries
99.1(5) - Certification of William F. Borne, Chief Executive Officer
99.2(5) - Certification of Gregory H. Browne, Chief Financial Officer
(1) Previously filed as an exhibit to the Registration Statement on Form S-3
dated March 11, 1998.
19
(2) Previously filed as an exhibit to the Current Report on Form 8-K dated June
16, 2000 and the Registration Statement on Form 8-A dated June 16, 2000.
(3) Previously filed as an exhibit to the Quarterly Report on Form 10-Q for the
period ended March 31, 2001.
(4) Previously filed as an exhibit to the Quarterly Report on Form 10-Q for the
period ended March 31, 2002.
(5) Filed herewith.
(b) Reports on Form 8-K
On April 29, 2002, the Company filed a Current Report on Form 8-K with
the SEC attaching a press release announcing the completion of a $9.5 million
private placement of common stock and announcing that results for the quarter
ended March 31, 2002 will be released on May 6, 2002 with a conference call to
be held the same day.
On May 3, 2002, the Company filed a Current Report on Form 8-K with the
SEC due to the decision, by the Board of Directors, to dismiss Arthur Andersen
LLP as the independent auditors of the Company.
On May 13, 2002, the Company filed a Current Report on Form 8-K/A with
the SEC in connection with the dismissal of Arthur Andersen LLP as the
independent auditors of the Company.
On May 24, 2002, the Company filed a Current Report on Form 8-K/A with
the SEC to announce that the Company has engaged KPMG LLP as the Company's
independent auditors for fiscal year 2002.
On May 28, 2002, the Company filed a Current Report on Form 8-K with
the SEC attaching a press release announcing the appointment of KPMG LLP as the
Company's independent auditors for fiscal year 2002.
On June 5, 2002, the Company filed a Current Report on Form 8-K with
the SEC attaching a press release announcing the appointment of Gregory H.
Browne as Chief Financial Officer.
On June 25, 2002, the Company filed a Current Report on Form 8-K with
the SEC pursuant to Section 18 under the Securities Act of 1934 to furnish the
text of slides which the Company's management began using in presentations at
investor conferences.
20
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
AMEDISYS, INC.
By: /s/ GREGORY H. BROWNE
------------------------------
Gregory H. Browne
Chief Financial Officer
DATE: August 14, 2002
21
INDEX TO EXHIBITS
Exhibit
No. Identification of Exhibit
------- -------------------------
3.1(4) - Certificate of Incorporation
3.2(3) - Bylaws
4.2(1) - Common Stock Specimen
4.7(2) - Shareholder Rights Agreement
10.1(5) - Employment Agreement between Amedisys, Inc. and Greg Browne
21.1(1) - List of Subsidiaries
99.1(5) - Certification of William F. Borne, Chief Executive Officer
99.2(5) - Certification of Gregory H. Browne, Chief Financial Officer
(1) Previously filed as an exhibit to the Registration Statement on Form S-3
dated March 11, 1998.
(2) Previously filed as an exhibit to the Current Report on Form 8-K dated June
16, 2000 and the Registration Statement on Form 8-A dated June 16, 2000.
(3) Previously filed as an exhibit to the Quarterly Report on Form 10-Q for the
period ended March 31, 2001.
(4) Previously filed as an exhibit to the Quarterly Report on Form 10-Q for the
period ended March 31, 2002.
(5) Filed herewith.
22